CRP and cardiovascular disorder: The Women’s Health study demonstrated that the addition of hs-CRP to the Framingham score improved the predictive accuracy of cardiovascular risk, especially in women with a 5–20% risk in 10 years.14 Evidence from the Women’s Ischemia Syndrome Evaluation, a prospective study, reported that high levels of amyloid serum A, IL-6, sICAM1 and CRP had the highest predictive accuracy in 27 347 postmenopausal women apparently without cardiovascular disease.15 The guidelines do not however recommend routine evaluation of this inflammatory biomarker, CRP.2,11